New targets for the treatment of advanced non-small cell lung cancer.
Massarelli
Erminia
E
Department of Thoracic/Head and Neck Medical Oncology, University of Texas, M.D. Anderson Cancer Center, P.O. Box 432, Houston, TX 77030, USA.
Onn
Amir
A
Zinner
Ralph
R
Khuri
Fadlo R
FR
Kim
Edward S
ES
Herbst
Roy S
RS
D019883:Alkyl and Aryl Transferases / Q000037:antagonists & inhibitors; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000628:therapy*; D003131:Combined Modality Therapy; D051231:Farnesyltranstransferase; D015316:Genetic Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D019883:Alkyl and Aryl Transferases; D051231:Farnesyltranstransferase